• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本有无Brugada综合征患者皮下植入式心律转复除颤器的体表心电图筛查

Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada Syndrome.

作者信息

Kawabata Mihoko, Goya Masahiko, Sasaki Takeshi, Maeda Shingo, Yagishita Atsuhiko, Shirai Yasuhiro, Kaneko Masakazu, Shiohira Shinya, Isobe Mitsuaki, Hirao Kenzo

机构信息

Heart Rhythm Center, Tokyo Medical and Dental University.

Department of Cardiovascular Medicine, Tokyo Medical and Dental University.

出版信息

Circ J. 2017 Jun 23;81(7):981-987. doi: 10.1253/circj.CJ-16-1295. Epub 2017 Mar 28.

DOI:10.1253/circj.CJ-16-1295
PMID:28367844
Abstract

BACKGROUND

Subcutaneous implantable cardioverter-defibrillators (S-ICD) could eliminate lead-associated complications. We assessed the prevalence of S-ICD ineligibility in conventional ICD recipients and compared it in patients with and without Brugada syndrome (BrS).

METHODS AND RESULTS

Consecutive patients with a transvenous ICD without an indication for antibradycardia pacing were assessed. A patient was considered eligible for S-ICD if the ECG satisfied the screening template, both supine and standing, in ≥1 lead. Among 130 patients (103 men, age 57±15 years), a total of 18 (13.8%) patients were ineligible. The BrS group (n=33) had a significantly higher prevalence of S-ICD screening failure as compared with the non-BrS group (P=0.003; 30% vs. 8.2%). In the BrS group, the body mass index (BMI) was significantly lower, and T/QRS amplitude in lead I was significantly higher in those who were ineligible than that in the patients who were eligible. Of the 10 BrS patients failing the screening, 4 became eligible in the right parasternal electrode position.

CONCLUSIONS

Among current ICD patients, there was a high incidence of patients with BrS who were unsuitable for S-ICD based on the left parasternal screening test. Suitability screening of patients for S-ICDs should be conducted carefully in patients with BrS, particularly if the BMI is low. Right parasternal electrode positioning should also be tested in such BrS patients.

摘要

背景

皮下植入式心律转复除颤器(S-ICD)可消除与导线相关的并发症。我们评估了传统ICD植入患者中S-ICD不适用的发生率,并比较了有和没有Brugada综合征(BrS)患者的情况。

方法与结果

对连续的经静脉植入ICD且无抗心动过缓起搏指征的患者进行评估。如果心电图在≥1个导联中仰卧位和站立位均符合筛查模板,则该患者被认为适合植入S-ICD。在130例患者(103例男性,年龄57±15岁)中,共有18例(13.8%)患者不适合。与非BrS组相比,BrS组(n = 33)的S-ICD筛查失败率显著更高(P = 0.003;30%对8.2%)。在BrS组中,不适合的患者体重指数(BMI)显著更低,I导联的T/QRS振幅显著高于适合的患者。在10例筛查失败的BrS患者中,4例在右胸骨旁电极位置变为适合。

结论

在目前的ICD患者中,基于左胸骨旁筛查试验,有较高比例的BrS患者不适合S-ICD。对于BrS患者,尤其是BMI较低的患者,应仔细进行S-ICD的适用性筛查。对于此类BrS患者,还应测试右胸骨旁电极定位。

相似文献

1
Surface Electrocardiogram Screening for Subcutaneous Implantable Cardioverter-Defibrillators in Japanese Patients With and Without Brugada Syndrome.日本有无Brugada综合征患者皮下植入式心律转复除颤器的体表心电图筛查
Circ J. 2017 Jun 23;81(7):981-987. doi: 10.1253/circj.CJ-16-1295. Epub 2017 Mar 28.
2
Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.运动负荷试验显示,布加综合征患者不适合植入皮下植入式心律转复除颤器。
J Cardiovasc Electrophysiol. 2017 Dec;28(12):1454-1459. doi: 10.1111/jce.13315. Epub 2017 Sep 1.
3
Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.皮下植入式心脏复律除颤器治疗 Brugada 综合征患者的有效性。
Heart Vessels. 2021 Feb;36(2):260-266. doi: 10.1007/s00380-020-01683-0. Epub 2020 Aug 24.
4
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.SMART Pass 滤器对阿义马林诱导 Brugada 综合征和皮下植入式心脏复律除颤器植入失败患者的影响:前瞻性多中心研究结果。
Europace. 2022 May 3;24(5):845-854. doi: 10.1093/europace/euab230.
5
High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes.Brugada 综合征患者皮下植入式心律转复除颤器感知筛查失败率高:与其他遗传性原发性心律失常综合征的比较。
Europace. 2018 Jul 1;20(7):1188-1193. doi: 10.1093/europace/eux009.
6
Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test.Brugada 综合征:运动应激试验后皮下植入式心脏复律除颤器的适应证。
Rev Port Cardiol (Engl Ed). 2021 Jan;40(1):33-38. doi: 10.1016/j.repc.2020.05.013. Epub 2021 Jan 9.
7
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.药物诱导 1 型 ECG 图形 Brugada 综合征患者中皮下与经静脉植入式心脏复律除颤器的比较:来自 IBRYD 研究的倾向评分匹配分析。
Heart Vessels. 2023 May;38(5):680-688. doi: 10.1007/s00380-022-02204-x. Epub 2022 Nov 24.
8
Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators.QRS 波群和 T 波的日间变化对皮下植入式心脏除颤器适应证的影响。
Heart Rhythm. 2019 Jun;16(6):913-920. doi: 10.1016/j.hrthm.2019.01.004. Epub 2019 Jan 4.
9
Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.药物激发试验期间心电图筛查对预测 Brugada 综合征患者皮下植入式心律转复除颤器 T 波过度感知的影响。
Heart Vessels. 2017 Oct;32(10):1277-1283. doi: 10.1007/s00380-017-0994-3. Epub 2017 May 18.
10
Inappropriate Shocks in Brugada Syndrome Patients With a Subcutaneous Implantable Cardioverter Defibrillator.
Pacing Clin Electrophysiol. 2025 Feb;48(2):160-168. doi: 10.1111/pace.15151. Epub 2025 Jan 27.

引用本文的文献

1
Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes.来自EFFORTLESS队列的离子通道病患者皮下植入式心脏复律除颤器性能评估及与经静脉植入式心律转复除颤器结局的荟萃分析比较。
Heart Rhythm O2. 2020 Oct 28;1(5):326-335. doi: 10.1016/j.hroo.2020.10.002. eCollection 2020 Dec.